These data indicate that 13-MTD inhibits proliferation and induces apoptosis through the down-regulation of AKT phosphorylation followed by caspase activation, which may provide a new approach for treating T-cell lymphomas. This evidence concerns the gene AKT1 and T-cell non-Hodgkin lymphoma.